We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+9.54%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$99.2B
AUM Growth
+$5.03B
(+5.3%)
Cap. Flow
-$3.09B
Cap. Flow
% of AUM
-3.12%
Top 10 Holdings %
Top 10 Hldgs %
19.66%
Holding
3,988
New
43
Increased
2,065
Reduced
941
Closed
658
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$283M |
| 2 |
Microsoft
MSFT
|
+$139M |
| 3 |
UBS Group
UBS
|
+$131M |
| 4 |
Mercado Libre
MELI
|
+$96.4M |
| 5 |
Alcon
ALC
|
+$66.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$309M |
| 2 |
iShares China Large-Cap ETF
FXI
|
+$230M |
| 3 |
Apple
AAPL
|
+$226M |
| 4 |
Alibaba
BABA
|
+$225M |
| 5 |
Morgan Stanley
MS
|
+$214M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.84% |
| 2 | Healthcare | 15.57% |
| 3 | Financials | 13.55% |
| 4 | Consumer Discretionary | 9.29% |
| 5 | Industrials | 8.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Clarus
CLAR
$146M
| $175K | ﹤0.01% |
18,497
+6
| +0% | +$56 |
|
3027
Altimmune
ALT
$597M
| $175K | ﹤0.01% |
41,372
+3,235
| +8% | +$38.4K |
|
|
LEV
3028
DELISTED
The Lion Electric Company
LEV
| $172K | ﹤0.01% |
92,314
-295
| -0.3% | -$666 |
|
3029
Butterfly Network
BFLY
$2.28B
| $170K | ﹤0.01% |
90,581
+14,539
| +19% | +$34K |
|
3030
Alkami Technology
ALKT
$2.09B
| $170K | ﹤0.01% |
13,442
+998
| +8% | +$14.7K |
|
3031
Hyliion Holdings
HYLN
$708M
| $167K | ﹤0.01% |
84,594
+30
| +0% | +$84 |
|
|
KLRS
3032
Kalaris Therapeutics
KLRS
$97.5M
| $165K | ﹤0.01% |
1,825
+208
| +13% | +$26.5K |
|
3033
Douglas Elliman
DOUG
$163M
| $164K | ﹤0.01% |
55,231
+20
| +0% | +$80 |
|
3034
CarParts.com
PRTS
$51.8M
| $162K | ﹤0.01% |
3,040
+628
| +26% | +$39.8K |
|
3035
Kodiak Sciences
KOD
$2.86B
| $161K | ﹤0.01% |
26,030
+9
| +0% | +$63 |
|
|
SHCO
3036
DELISTED
Soho House & Co
SHCO
| $159K | ﹤0.01% |
24,330
+8
| +0% | +$48 |
|
3037
Dream Finders Homes
DFH
$1.29B
| $158K | ﹤0.01% |
11,923
+5
| +0% | +$59 |
|
|
RAIN
3038
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $157K | ﹤0.01% |
18,000
| – | – |
|
|
CTEV
3039
Claritev Corp
CTEV
$513M
| $156K | ﹤0.01% |
3,673
+1
| +0% | +$45 |
|
|
IGMS
3040
DELISTED
IGM Biosciences
IGMS
| $154K | ﹤0.01% |
11,211
+2,823
| +34% | +$58.4K |
|
3041
Lexicon Pharmaceuticals
LXRX
$1.04B
| $154K | ﹤0.01% |
63,385
+20
| +0% | +$46 |
|
3042
Dianthus Therapeutics
DNTH
$6.04B
| $154K | ﹤0.01% |
12,094
| – | – |
|
3043
ProFrac Holding
ACDC
$843M
| $154K | ﹤0.01% |
12,120
+4
| +0% | +$78 |
|
|
NGM
3044
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $153K | ﹤0.01% |
37,582
+2,988
| +9% | +$13.8K |
|
3045
Latham Group
SWIM
$867M
| $153K | ﹤0.01% |
53,475
+1,318
| +3% | +$4.63K |
|
3046
Root
ROOT
$805M
| $152K | ﹤0.01% |
33,779
+1,214
| +4% | +$6.15K |
|
3047
Precigen
PGEN
$2.53B
| $149K | ﹤0.01% |
140,874
+26,932
| +24% | +$38.8K |
|
|
MHN
3048
DELISTED
BlackRock MuniHoldings New Yrok Quality Fund
MHN
| $149K | ﹤0.01% |
14,000
-100
| -0.7% | -$1.06K |
|
3049
Fulcrum Therapeutics
FULC
$289M
| $148K | ﹤0.01% |
52,062
+8,242
| +19% | +$73.8K |
|
3050
El Pollo Loco
LOCO
$475M
| $147K | ﹤0.01% |
15,354
+2,672
| +21% | +$30.4K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q1 2023 Portfolio in Review
As of Q1 2023, Credit Suisse held 3,988 positions worth $99.2B, up 5.3% from $94.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Credit Suisse withdrew a net $3.09B in Q1 2023, closing 658 positions and reducing 941 holdings. Its most notable exit was Cresud SACIF y A. Warrant, an estimated $59.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Credit Suisse opened a new position in GE HealthCare worth $34.2M.
- Credit Suisse's largest Q1 2023 buy was GE HealthCare: 417,250 shares worth $34.2M.
- Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $283M increase.
- Credit Suisse's biggest Q1 2023 reduction was Amazon, cutting an estimated $309M.
- Credit Suisse fully exited Cresud SACIF y A. Warrant in Q1 2023, selling an estimated $59.2M.
- Credit Suisse's ten largest holdings make up 20% of its $99.2B portfolio in Q1 2023.
- Credit Suisse opened 43 new positions and closed 658 in Q1 2023.
- Credit Suisse's portfolio value rose 5.3% quarter-over-quarter to $99.2B.
Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.